Heidelberg Study on Diabetes and Complications - Trial NCT03022721
Access comprehensive clinical trial information for NCT03022721 through Pure Global AI's free database. This phase not specified trial is sponsored by Heidelberg University and is currently Recruiting. The study focuses on Diabetes Complications. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Heidelberg University
Timeline & Enrollment
N/A
Sep 01, 2016
Sep 01, 2028
Primary Outcome
Development of diabetic complications
Summary
The prospective observational study entitled Heidelberg Study on Diabetes and Complications
 is designed to Monitor the presence and development of diabetic complications in type 1 and
 type 2 diabetic patients, as well as pre-diabetics. Mail Goal is to detect new metabolic
 mechanisms or new risk factors for the development of diabetic complications in order to
 identify risk-subgroups. Non-diabetic controls will be enrolled for reference and comparison.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03022721
Non-Device Trial